Known glucose-lowering medication status of these donors with diabetes did not significantly correlate with any insulin-secretion parameters; however, there was an overall trend with the need for exogenous insulin and lower overall insulin secretory capacity (Figures S2J–S2Q). This evidence concerns the gene INS and diabetes mellitus.